Wcg Wealth Advisors LLC Abb Vie Inc. Transaction History

Wcg Wealth Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $383,727 - $437,222	-2,401 Reduced 17.52%	11,301 $2.06 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $116,684 - $131,414	848 Added 6.6%	13,702 $2.12 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $1.72 Million - $1.99 Million	12,854 New	12,854 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $10,065 - $11,544	75 Added 4.85%	1,622 $218,000
Q2 2022 Aug 23, 2022	SELL	$137.62 - $174.96 $73,626 - $93,603	-535 Reduced 25.7%	1,547 $237,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $286,524 - $364,266	2,082 New	2,082 $249,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wcg Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Wcg Wealth Advisors LLC with notifications on news.